Industry Developments

In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed... 2008-06-24

The Swiss biotech sector attracted record levels of investment and healthy market growth during 2007, according Swiss Biotech's 2008 annual report. However, while company revenues... 2008-06-20

New GlaxoSmithKline CEO Andrew Witty has put forward plans for the company's strategy, with a combination of more focused research strategies and a diversification of interests. Witty,... 2008-06-17

In a development that could significantly cut the cost of producing biopharmaceuticals, Dutch firms DSM Biologics and Crucell have announced record yield results using Crucell's human... 2008-06-17

As a result of the growing popularity of investing in ethical companies, along with the ongoing goal of providing developing countries with better access to medicines, the Netherlands-based... 2008-06-16

BMI believes there is significant global growth potential for third party active pharmaceutical ingredient (API) inspection firms over the next few years. This is in light of the... 2008-06-12

European wholesale and retail pharmacy giant Alliance Boots has seen trading profits rise by 20% year-on-year (y-o-y) for 2007, a positive performance for the company, which was 2007's... 2008-06-12

AstraZeneca has asked a US judge to throw out or reduce the US$215mn fine that resulted from a Medicaid drug price fraud lawsuit. The UK drugmaker was found liable for misrepresentation... 2008-06-11

Switzerland-based drugmaker Nycomed is planning to sell part of its oncology pipeline to German firm 4SC in order to focus on developing drugs in its current areas of speciality.... 2008-06-06

Swiss pharmaceutical giant Novartis is to acquire US antibiotic developer Protez Pharmaceuticals in a deal worth up to US$400mn. Protez will become an independently-run subsidiary... 2008-06-05